Pancreatic Cancer Research

ResearcherInstitutul Clinic FundeniActive in the last 2 years

Irinel Popescu

ORCID-verified (high confidence, 0.95), identity_conf@1As of 6 November 2026

Matched on ORCID iD 0000-0002-2897-1170; OpenAlex author ID A5023690844. Sources: OpenAlex.

Their work

Papers
20 (first author 1, last author 8)
Trials
0
Grants
0
Labs led
1
Collaborators
51
Papers, trials and grants by year

2012: 3 papers · 2013: 1 paper · 2014: 1 paper · 2015: 2 papers · 2016: none · 2017: none · 2018: 5 papers · 2019: none · 2020: 3 papers · 2021: none · 2022: 3 papers · 2023: 1 paper · 2024: 1 paper

Papers 20

  1. Prognostic Value of Circulating Cell-Free DNA Concentration and Neutrophil-to-Lymphocyte Ratio in Patients with Pancreatic Ductal Adenocarcinoma: A Prospective… Co-author DOI 10.3390/ijms25052854↗
  2. Endoscopic ultrasound-guided fine-needle aspiration pancreatic adenocarcinoma samples yield adequate DNA for next-generation sequencing: A cohort analysis. Co-author DOI 10.3748/wjg.v29.i18.2864↗
  3. Pancreatico-Duodenectomy for Pancreatic Ductal Adenocarcinoma: from Artery-First Approaches toTRIANGLE Operation. First author DOI 10.21614/chirurgia.2771↗
  4. Using Molecular Subtyping of Pancreatic Ductal Adenocarcinoma for Multimodal Treatment Selection in Resectable Disease. Co-author DOI 10.21614/chirurgia.2772↗
  5. The Association between TRP Channels Expression and Clinicopathological Characteristics of Patients with Pancreatic Adenocarcinoma. Co-author DOI 10.3390/ijms23169045↗
  6. A Morphological and Immunohistochemical Study of the Tumoral and Inflammatory Cells in Pancreatic Ductal Adenocarcinoma. Last author DOI 10.1155/2020/6148286↗
  7. Pancreatoduodenectomy After Neoadjuvant Chemotherapy for Locally Advanced Pancreatic Cancer in the Presence of an Aberrant Right Hepatic Artery. Last author DOI 10.21873/invivo.11788↗
  8. Morphometric Assessment of Confocal Laser Endomicroscopy for Pancreatic Ductal Adenocarcinoma, an Ex-Vivo Pilot Study. Co-author DOI 10.3390/diagnostics10110923↗
  9. Outcomes After Distal Pancreatectomy with Celiac Axis Resection for Pancreatic Cancer: A Pan-European Retrospective Cohort Study. Co-author DOI 10.1245/s10434-018-6391-z↗
  10. Correction to: Outcomes After Distal Pancreatectomy with Celiac Axis Resection for Pancreatic Cancer: A Pan-European Retrospective Cohort Study. Co-author DOI 10.1245/s10434-018-6442-5↗
  11. Early detection of advanced pancreatic cancer after DAA-induced virological cure in a liver transplant recipient with hepatitis C recurrence Co-author DOI 10.15403/jgld.2014.1121.271.daa↗
  12. What is the Value of Total Mesopancreas Excision in Pancreatic Ductal Adenocarcinoma? Current Evidence of the Literature. Co-author DOI 10.21614/chirurgia.113.3.335↗
  13. One Hundred Pancreatectomies with Venous Resection for Pancreatic Adenocarcinoma. Last author DOI 10.21614/chirurgia.113.3.363↗
  14. Epigenetic Silencing of GNMT Gene in Pancreatic Adenocarcinoma. Last author PMID 25560641↗
  15. Impact of Hepatitis B Virus on Clinicopathological Features and Outcomes After Resection for Pancreatic Adenocarcinoma. Last author PMID 26254417↗
  16. Characterization of functional transient receptor potential melastatin 8 channels in human pancreatic ductal adenocarcinoma cells. Last author DOI 10.1097/mpa.0000000000000106↗
  17. Assessment of the stromal contribution to Sonic Hedgehog-dependent pancreatic adenocarcinoma. Co-author DOI 10.1016/j.molonc.2013.08.004↗
  18. An exploratory study of inflammatory cytokines as prognostic biomarkers in patients with ductal pancreatic adenocarcinoma. Last author DOI 10.1097/mpa.0b013e3182546e13↗
  19. Morphometrical differences between resectable and non-resectable pancreatic cancer: a fractal analysis. Co-author DOI 10.5754/hge11277↗
  20. Update in pancreatic cancer surgery - focus on total mesopancreas excision. Last author PMID 23118831↗

Closest collaborators

The 25 strongest of 51 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Simona Dima · 13 shared papers, 2012–2024 · strength 1.38
  2. Traian Dumitraşcu · 10 shared papers, 2012–2022 · strength 1.14
  3. Cristian Gheorghe · 3 shared papers, 2018–2024 · strength 0.44
  4. Dan Gabriel Duda · 4 shared papers, 2012–2022 · strength 0.35
  5. Vladislav Braşoveanu · 4 shared papers, 2015–2020 · strength 0.35
  6. Ștefania Bunduc · 2 shared papers, 2023–2024 · strength 0.35
  7. Bianca Varzaru · 2 shared papers, 2023–2024 · strength 0.35
  8. Vlad Herlea · 4 shared papers, 2012–2020 · strength 0.22
  9. Dana Cucu · 2 shared papers, 2014–2022 · strength 0.20
  10. Nicolae Bacalbașa · 2 shared papers, 2015–2020 · strength 0.17
  11. Florentina Cojocaru · 1 shared paper, 2022 · strength 0.16
  12. Nicoleta-Raluca Chelaru · 1 shared paper, 2022 · strength 0.16
  13. Cătălin Vasilescu · 2 shared papers, 2012–2020 · strength 0.13
  14. Bogdan Silviu Ungureanu · 1 shared paper, 2020 · strength 0.13
  15. Valeriu Şurlin · 1 shared paper, 2020 · strength 0.13
  16. Adrian Săftoiu · 1 shared paper, 2020 · strength 0.13
  17. Iulian Brezean · 1 shared paper, 2020 · strength 0.12
  18. Irina Bălescu · 1 shared paper, 2020 · strength 0.12
  19. Helmut Frieß · 2 shared papers, 2018 · strength 0.10
  20. Matteo De Pastena · 2 shared papers, 2018 · strength 0.10
  21. Willem Niesen · 2 shared papers, 2018 · strength 0.10
  22. Manuela Cesaretti · 2 shared papers, 2018 · strength 0.10
  23. Sjors Klompmaker · 2 shared papers, 2018 · strength 0.10
  24. Frederik Christiaan Berrevoet · 2 shared papers, 2018 · strength 0.10
  25. Mustapha Adham · 2 shared papers, 2018 · strength 0.10

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.